Bob Nordgren is a highly experienced professional in the animal health sector, currently serving as Vaccine Lead at ArkeaBioâ„¢ since May 2024. As Managing Partner at Covenant Animal Health Partners since January 2022, Bob collaborates with Covenant Partner and NovaQuest to introduce new products to the market. Additional roles include U.S. Lab Support at MI:RNA Diagnostics and Managing Director at Aix Bio Consulting, both starting in March 2022 and May 2016, respectively. Bob is also a Managing Partner at Reliance Animal Health Partners and The Yield Lab, and Chairman at APTIMMUNE BIOLOGICS, INC. Previous experience includes Chief Development Officer at Curtiss Healthcare Inc. until October 2024, and various leadership roles at Merial, a Sanofi Company, and Boehringer Ingelheim Vetmedica. Educational qualifications include an MS and PhD in Veterinary Immunology and Parasitology from Texas A&M University, and a Bachelor of Science in Zoology/Animal Biology from Knox College.
Links